Logo

Applera Board Authorizes Additional Applied Biosystems Stock Buyback

Apr 05, 2004

NEW YORK, April 5 (GenomeWeb News) - Applera has authorized the repurchase of up to $100 million of its Applied Biosystems group's common stock, ABI said today.

 

The repurchase, approved by Applera's board of directors, has no time restrictions. Applera already repurchased $200 million, or 8.9 million shares, of Applied Biosystems' stock during fiscal year 2004.

Breaking News
The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.